Citius Oncology Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.61

-0.01 (-1.44%)

As of Apr 1, 3:06 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +5,127.5% upside

Low Target $22.24

Average Target $31.94

High Target $42.20

Current Price $0.61

Current
$0.61

Target
$31.94

$22.24 $31.94 avg $42.20

Scenario Analysis

Bear Case

$22.24

3,539.9%

Low target

Base Case

$31.94

+5,127.5%

Avg target

Bull Case

$42.20

+6,806.7%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$6.19

-90.1% from high

52-Week Low

$0.52

+17.5% from low

Target vs 52W High

$31.94

+416.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%